Patents by Inventor Kenji Soejima

Kenji Soejima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11186630
    Abstract: A human antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The human antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a human antibody suitable for application to human body.
    Type: Grant
    Filed: February 6, 2020
    Date of Patent: November 30, 2021
    Assignee: KM BIOLOGICS CO., LTD.
    Inventors: Masaharu Torikai, Akihiko Hosoi, Tomoyo Takeo, Masayo Ueno, Kenji Soejima, Toshihiro Nakashima, Yukio Ando, Hirofumi Jono, Yu Su, Mineyuki Mizuguchi
  • Publication number: 20200181250
    Abstract: A human antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The human antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a human antibody suitable for application to human body.
    Type: Application
    Filed: February 6, 2020
    Publication date: June 11, 2020
    Applicant: KM Biologics Co., Ltd.
    Inventors: Masaharu TORIKAI, Akihiko HOSOI, Tomoyo TAKEO, Masayo UENO, Kenji SOEJIMA, Toshihiro NAKASHIMA, Yukio ANDO, Hirofumi JONO, Yu SU, Mineyuki MIZUGUCHI
  • Patent number: 10604562
    Abstract: A humanized antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The humanized antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a humanized antibody suitable for application to human body.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: March 31, 2020
    Assignees: KM BIOLOGICS CO., LTD., NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
    Inventors: Akihiko Hosoi, Masaharu Torikai, Tomoyo Takeo, Masayo Ueno, Hirofumi Higuchi, Kenji Soejima, Toshihiro Nakashima, Yukio Ando, Hirofumi Jono, Yu Su
  • Patent number: 10597440
    Abstract: A human antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The human antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a human antibody suitable for application to human body.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: March 24, 2020
    Assignee: KM BIOLOGICS CO., LTD.
    Inventors: Masaharu Torikai, Akihiko Hosoi, Tomoyo Takeo, Masayo Ueno, Kenji Soejima, Toshihiro Nakashima, Yukio Ando, Hirofumi Jono, Yu Su, Mineyuki Mizuguchi
  • Patent number: 10570199
    Abstract: The present invention relates to a human anti-human IL-18 antibody which reacts with human interleukin-18 (human IL-18) and does not react with a K53A variant of human IL-18.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: February 25, 2020
    Assignee: KM Biologics Co., Ltd.
    Inventors: Hiroyuki Shimizu, Miyuki Matsumoto, Kenji Soejima, Masaharu Torikai, Toshihiro Nakashima
  • Publication number: 20190077858
    Abstract: The present invention relates to a human anti-human IL-18 antibody which reacts with human interleukin-18 (human IL-18) and does not react with a K53A variant of human IL-18.
    Type: Application
    Filed: November 18, 2013
    Publication date: March 14, 2019
    Inventors: Hiroyuki Shimizu, Miyuki Matsumoto, Kenji Soejima, Masaharu Torikai, Toshihiro Nakashima
  • Patent number: 10171294
    Abstract: Consistency between a requirement for communication with respect to software in a system and a requirement for a network is maintained, without re-designing a network by the user. A requirement conversion unit (110) of a system design support device (100) generates a requirement for communication between computers based on a requirement for communication between software components included in a system, and based on identifiers of the computers in which the software components are deployed. The requirement conversion unit (110) generates a requirement for a network for connecting between the computers based on the requirement for communication between the computers.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: January 1, 2019
    Assignee: NEC CORPORATION
    Inventor: Kenji Soejima
  • Patent number: 9921882
    Abstract: An objective of the present invention is to construct a system in which a plurality of software components having dependencies are deployed dispersedly on a plurality of processing devices. The information system includes a deployment device (100) and a plurality of processing devices (200). A scheduler (210) of the processing device (200) determine whether there is a deployment task satisfying an execution condition in task information (231) on the basis of a termination event of a deployment task. When there is a deployment task satisfying the execution condition, the scheduler (210) executes the deployment task and transmits a termination event of the deployment task to the deployment device (100). An event processing unit (130) of the deployment device (100) transmits the termination event of the deployment task to a notification destination processing device (200) referring to event information (141).
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: March 20, 2018
    Assignee: NEC CORPORATION
    Inventor: Kenji Soejima
  • Publication number: 20160347832
    Abstract: A humanized antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The humanized antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a humanized antibody suitable for application to human body.
    Type: Application
    Filed: January 23, 2015
    Publication date: December 1, 2016
    Applicants: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE, NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSIT Y
    Inventors: Akihiko HOSOI, Masaharu TORIKAI, Tomoyo TAKEO, Masayo UENO, Hirofumi HIGUCHI, Kenji SOEJIMA, Toshihiro NAKASHIMA, Yukio ANDO, Hirofumi JONO, Yu SU
  • Publication number: 20160340419
    Abstract: A human antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The human antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a human antibody suitable for application to human body.
    Type: Application
    Filed: January 23, 2015
    Publication date: November 24, 2016
    Applicant: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
    Inventors: Masaharu TORIKAI, Akihiko HOSOI, Tomoyo TAKEO, Masayo UENO, Kenji SOEJIMA, Toshihiro NAKASHIMA, Yukio ANDO, Hirofumi JONO, Yu SU, Mineyuki MIZUGUCHI
  • Publication number: 20160197779
    Abstract: Consistency between a requirement for communication with respect to software in a system and a requirement for a network is maintained, without re-designing a network by the user. A requirement conversion unit (110) of a system design support device (100) generates a requirement for communication between computers based on a requirement for communication between software components included in a system, and based on identifiers of the computers in which the software components are deployed. The requirement conversion unit (110) generates a requirement for a network for connecting between the computers based on the requirement for communication between the computers.
    Type: Application
    Filed: August 21, 2014
    Publication date: July 7, 2016
    Inventor: Kenji Soejima
  • Patent number: 9342382
    Abstract: Internal processes of specified components are connected to each other when an application is executed regardless of interface definition between the components and a new process is executed. A program processing apparatus (100) includes an aspect application unit (102) which generates a routing unit (201) and a connector unit (301) and applies the routing unit (201) and the connector unit (301), respectively to a component (200) and a component (300) which are included in an activated program, and a configuration management unit (101) which causes the routing unit (201) applied to the component (200) and the connector unit (301) applied to the component (300) to establish a communication connection with each other and causes the component (300) to send a process result of an process instruction in the component (300) to the component (200) through the established communication connection.
    Type: Grant
    Filed: February 2, 2011
    Date of Patent: May 17, 2016
    Assignee: NEC CORPORATION
    Inventor: Kenji Soejima
  • Publication number: 20160034315
    Abstract: An objective of the present invention is to construct a system in which a plurality of software components having dependencies are deployed dispersedly on a plurality of processing devices. The information system includes a deployment device (100) and a plurality of processing devices (200). A scheduler (210) of the processing device (200) determine whether there is a deployment task satisfying an execution condition in task information (231) on the basis of a termination event of a deployment task. When there is a deployment task satisfying the execution condition, the scheduler (210) executes the deployment task and transmits a termination event of the deployment task to the deployment device (100). An event processing unit (130) of the deployment device (100) transmits the termination event of the deployment task to a notification destination processing device (200) referring to event information (141).
    Type: Application
    Filed: April 15, 2014
    Publication date: February 4, 2016
    Applicant: NEC Corporation
    Inventor: Kenji SOEJIMA
  • Publication number: 20150277940
    Abstract: A program setting device to allow setting items of a program to be flexibly defined in accordance with a level of skill of a user is provided. A program setting device (100) includes a concretization logic execution unit (121) and a set value determination unit (120). The concretization logic execution unit (121) executes a concretization logic (311) for calculating a concrete setting item (302) which is a setting item specific to each of a plurality of implementations of a program from an abstract setting item (202) which is a setting item common to the plurality of implementations of the program.
    Type: Application
    Filed: November 14, 2013
    Publication date: October 1, 2015
    Applicant: NEC Corporation
    Inventor: Kenji Soejima
  • Patent number: 9109217
    Abstract: An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: August 18, 2015
    Assignee: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
    Inventor: Kenji Soejima
  • Patent number: 9003370
    Abstract: There are provided: a test executing section which generates a plurality of logs when executing a coverage test for an application based on an inputted parameter; and a result processing section which generates a point candidate report based on the plurality of logs. The plurality of logs respectively indicate a call stack of a method designating the parameter as an argument among a plurality of methods called during execution of the coverage test. The call stack indicates a location on the application, in which a call of the method is defined. The point candidate report indicates a candidate for a point in the application, for which a modification is necessary when a dispatch of process is executed based on the parameter.
    Type: Grant
    Filed: March 2, 2011
    Date of Patent: April 7, 2015
    Assignee: NEC Corporation
    Inventor: Kenji Soejima
  • Publication number: 20150050716
    Abstract: An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.
    Type: Application
    Filed: October 30, 2014
    Publication date: February 19, 2015
    Applicant: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
    Inventor: Kenji SOEJIMA
  • Publication number: 20150033204
    Abstract: A construction procedure of a system which is constructed by performing operations of plural types with respect to each of plural program modules is generated. A system-construction-procedure generating device (100) includes a dependency relationship storing unit (111), an operating procedure storing unit (112), and an operating procedure generating unit (102). The dependency relationship storing unit (111) stores dependency relationship information (121) indicating a dependency relationship (123) for each of one or more pairs of operations among a plurality of operations each expressed with a combination of one of a plurality of program modules and one of a plurality of operation types, the plurality of operations being required for system construction. The operating procedure storing unit (112) stores a procedure sequence (122) indicating a sequence for performing each of the plurality of operations.
    Type: Application
    Filed: February 18, 2013
    Publication date: January 29, 2015
    Applicant: NEC CORPORATION
    Inventor: Kenji Soejima
  • Patent number: 8906661
    Abstract: An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.
    Type: Grant
    Filed: January 28, 2014
    Date of Patent: December 9, 2014
    Assignee: The Chemo-Sero-Therapeutic Research Institute
    Inventor: Kenji Soejima
  • Publication number: 20140193881
    Abstract: An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.
    Type: Application
    Filed: January 28, 2014
    Publication date: July 10, 2014
    Applicant: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
    Inventor: Kenji SOEJIMA